My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    VANECK ETF TR PHARMACEUTICAL ETF (NASDAQ: PPH)

    Overview
    current price
    $106.47
    $106.47
    change
    -0.73 | -0.68%
    -0.73 | -0.68%
    Yesterday's Close
    107.20
    open
    107.78
    volume
    0.07 M
    30d. avg volume.
    0.22 M
    1 day
    106.42 - 107.78
    52 weeks
    81.74 - 112.58
    p/e
    0.00
    beta
    0.4611
    market cap
    0.92 B
    dividend yield
    2.02%
    Industry
    -
    PPH by TradingView
    News and Commentary
    Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk Novo Nordisk's (NVO&nbs...
    Pharmaceutical Stocks to Outperform in 2023 As the calendar turns to a new year, investors face a challenging set of circumstances. Inflation is trending lower but well above what is comfortable for the Federal Reserve or...
    Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...
    Pfizer Q2 Earnings Boost Pharmaceutical ETFs After Raising Vaccine Revenue Forecasts Pfizer (PFE 
    ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...
    ETF Weekly: Funds That are Affected by the Coronavirus Global markets have been impacted this week due to the outbreak of a coronavirus in China ahead of the Lunar New Year. Currently, the World Health Organization is setting out to...
    StockTwits
    StockTwits
    Most Shared
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Consumers Are Feeling The Squeeze — And That Could Be Walmart's Biggest Advantage
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?